लोड हो रहा है...

Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

BACKGROUND: Bisphosphonates are recommended for use as first-line therapy for the prevention and treatment of glucocorticoid-induced osteoporosis in adults. However, the appropriate usage of bisphosphonates for the prevention or treatment of glucocorticoid-induced osteoporosis in children remains un...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Pediatr Rheumatol Online J
मुख्य लेखकों: Inoue, Yuzaburo, Mitsunaga, Kanako, Yamamoto, Takeshi, Chiba, Koki, Yamaide, Fumiya, Nakano, Taiji, Morita, Yoshinori, Yamaide, Akiko, Suzuki, Shuichi, Arima, Takayasu, Yamaguchi, Ken-ichi, Tomiita, Minako, Shimojo, Naoki, Kohno, Yoichi
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2018
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006935/
https://ncbi.nlm.nih.gov/pubmed/29914510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-018-0258-5
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!